Find latest CLL videos · 100+ videos
XV Eurasian Hematology-Oncology Congress - EHOC 2024
N

A Clinical Case of Extranodal MZL of the Palatum Durum After CLL/SLL Treatment: Distinct Entity or Continuous Process

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Nevenka Ridova
By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Nevenka Ridova
10 views
October 6, 2024

Chapters

Case Selection for Marginal Zone Lymphoma

00:00

46-Year-Old Female with Enlarged Lymph Nodes

01:25

Diagnosis of CLL/SLL Lymphoma with MBL

02:53

Immunophenotype Consistency Question for MZL

04:28

SLL Progression & FCR Treatment Results

08:01

Emergence of Oral MALT Lymphoma Post-CLL/SLL

08:25

Essential IHC Markers for Diagnosing MALT Lymphoma

13:01

PET/CT Scanning & MALT-IPI Risk Assessment

15:58

R-CHOP Therapy Choice & Complete Remission Achieved

22:01

Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

Total Health

West Oncology Conference

Sat, Feb 8, 2025
19:19

Debates in CLL: Measuring MRD is NOT the SOC

UChicago Medicine

J. Soumerai

206 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

926 views
05:20

New

ASH 2024 Insights: Zanubrutinib in Acalabrutinib-Intolerant Patients…

2024 ASH Annual Meeting Insights Hub

M. Shadman

51 views
22:04

MZL: Current Management and Emerging Therapeutics

University of Miami Sylvester Comprehensive Cancer Center

I. Lossos

59 views
09:27

New

Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN…

Fox Chase Cancer Center

S. Nakhoda

26 views
44:29

Improving Lymphoma Outcomes: Optimizing Trial Design, Using Surrogat…

UChicago Medicine

A. Zelenetz

106 views
28:07

Caring for Patients With Lymphoma: Using Guidelines to Improve Quali…

Yale Cancer Center

S. Huntington, E. Winer

77 views
26:58

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

114 views
36:40

Penn Medicine Abramson Cancer Center Updates on Managing CLL/SLL Wit…

Penn Medicine Abramson Cancer Center

J. Carter, M. Hughes

368 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

873 views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

433 views
14:35

Case-Based Discussions in Lymphoma: 1L MCL, CD30+ T-Cell, and R/R CLL

Yale Cancer Center

S. Huntington, S. Kothari, T. Sethi

94 views
44:20

CLL: Genotype to Phenotype and Beyond

Yale Cancer Center

C. Wu

261 views
15:57

Realizing Precision Medicine in CLL: Remaining Challenges and Potent…

Richard Rosenquist Brandell

28 views
14:36

The Latest Data on New Therapies in FL and MZL

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

J. Carter

74 views
16:11

SOHO 2023: Treatment Options for Marginal Zone Lymphoma

SOHO 2023 Eleventh Annual Meeting

E. Zucca

115 views
13:04

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

287 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

823 views
29:32

CLL Case Discussion: Diagnosis and Managment of Richter Syndrome

XV Eurasian Hematology-Oncology Congress - EHOC 2024

M. Kamil Al Qayyim

9 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.2K views
AUTOPLAY